Brief: Iterum Therapeutics Reports Q4 And Full Year 2023 Financial Results
28/03/2024 11:12
March 28 (Reuters) - Iterum Therapeutics PLC ITRM.O :
* ITERUM THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2023
FINANCIAL RESULTS
* RESUBMISSION OF NDA ON TRACK FOR EARLY Q2 24
* CASH RUNWAY INTO 2025
Source text for Eikon: ID:nGNX5WKSpZ
Further company coverage: ITRM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity